Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J. Casinello"'
Publikováno v:
Pirineos: Revista de Ecología de Montaña, Vol 157, Pp 181-190 (2002)
[fr] La présence de l'aoudad, Ammotragus lervia, dans la Péninsule ibérique a été notée tant en populations en liberté qu'en réserves de chasse. Il a été confirmé que ce caprinae est présent dans 10 provinces et nous pensons qu'il l'est
Externí odkaz:
https://doaj.org/article/b09dd974161543e9b107f7a4ecdaadd8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Actas Urológicas Españolas (English Edition). 35:57-60
Introduction Systemic treatment options for patients with hormone-refractory prostate cancer (HRPC) that progress despite the use of Docetaxel are very limited. One of the options of compassionate use currently available is the use of Sunitinib. We p
Autor:
F Carabantes, A Murias, Manuel Constenla, P Regueiro, G Perez-Manga, M Söderberg, J Castellanos, Anna Ruiz, Kenneth Villman, M. González Barón, J Casinello, N Batista, J Ahlgren
Publikováno v:
British Journal of Cancer
The addition of oral capecitabine to docetaxel improves response rate, time to progression (TTP) and overall survival in anthracycline-pretreated metastatic breast cancer (MBC). This phase II study evaluates the efficacy and safety of a 21-day cycle
Publikováno v:
Pirineos: Revista de Ecología de Montaña, Vol 157, Iss 0, Pp 181-190 (2002)
Presence of the aoudad, Ammotragus lervia, in the Iberian Peninsula is shown, including both free-ranging populations and those in game reserves reported to be currently hosting the species. It has been confirmed that this caprinae is present, with c
Publikováno v:
Actas Urológicas Españolas v.35 n.1 2011
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumen Introduccion las opciones de tratamiento sistemico para los pacientes con cancer de prostata hormonorrefractario (CPHR) que progresan a pesar del uso de docetaxel son muy limitadas. Una de las opciones de uso compasivo disponibles en la actua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba3593fd8772c17fe1c83a81fa8feb3
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062011000100016
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062011000100016
Publikováno v:
Actas urologicas espanolas. 35(1)
systemic treatment options for patients with hormone-refractory prostate cancer (HRPC) that progress despite the use of Docetaxel are very limited. One of the options of compassionate use currently available is the use of Sunitinib. We present a join
Autor:
I. Sánchez-Magro, J. Carulla, V. Alberola, J. Casinello, Juan Antonio Virizuela, Carlos Camps, Y. Escobar
Publikováno v:
European Journal of Pain. 13
Publikováno v:
Archives of gynecology and obstetrics. 266(4)
We present the case of a 63-year-old woman with an ovarian neoplasm in which mucinous cystadenocarcinoma and choriocarcinoma coexisted. Blood levels of beta-hCG were elevated and bilateral ovarian stromal luteinization was seen. The rarity of this as
Autor:
Rosa Llorente, Cristina Llorca, Cristina Grávalos, J. Casinello, Luis Manso, Gustavo Catalan, A. García Palomo, J.I. Chacon Lopez-Muniz, E. Galve Calvo, Ramon Perez-Carrion
Publikováno v:
Annals of Oncology. 23:ix125
Background Combining bevacizumab (BEV) with chemotherapy (CT) improves survival in HER2-negative metastatic breast cancer (MBC). We investigated the influence of age, ECOG, hormonal status, number of sites and location of metastases and patient decis